ROTHBLATT MARTINE A (Chairperson & CEO) sold 19.0% of their position (9.50K shares) of UNITED THERAPEUTICS CORP on the open market

Open‑market sale worth $5.11M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 8 sales

ROTHBLATT MARTINE A

Filed: 6/3/2026ACC: 0001106578-26-000068

InsiderROTHBLATT MARTINE ACIK 1106578

→

IssuerUNITED THERAPEUTICS CORPCIK 1082554

DirectorOfficer· Chairperson & CEO

Since Mar 2026

-9.50K

Net shares

Net seller

$5.11M

Total sold

Open market trades

0B · 8S

Total transactions

9.50K acquired · 19K disposed

Non-Derivative Transactions9

Common Stock

Direct

M · Option Exercise

+9.50K

Price / share

$146.03

Trade value

$1.39M

% of position

23.4%

6/2/2026

40.51K→50.01K

Common Stock

Direct

S · Sale

−1.16K

Price / share

$535.69

Trade value

$621.40K

% of position

2.3%

6/2/2026

50.01K→48.85K

Common Stock

Direct

S · Sale

−2.06K

Price / share

$536.62

Trade value

$1.10M

% of position

4.2%

6/2/2026

48.85K→46.80K

Common Stock

Direct

S · Sale

−1.46K

Price / share

$537.62

Trade value

$787.08K

% of position

3.1%

6/2/2026

46.80K→45.33K

Common Stock

Direct

S · Sale

−1.15K

Price / share

$538.81

Trade value

$619.09K

% of position

2.5%

6/2/2026

45.33K→44.18K

Common Stock

Direct

S · Sale

−2.31K

Price / share

$539.83

Trade value

$1.25M

% of position

5.2%

6/2/2026

44.18K→41.87K

Common Stock

Direct

S · Sale

−641.00

Price / share

$540.48

Trade value

$346.45K

% of position

1.5%

6/2/2026

41.87K→41.23K

Common Stock

Direct

S · Sale

−440.00

Price / share

$541.68

Trade value

$238.34K

% of position

1.1%

6/2/2026

41.23K→40.79K

Common Stock

Direct

S · Sale

−280.00

Price / share

$543.26

Trade value

$152.11K

% of position

0.7%

6/2/2026

40.79K→40.51K

Total

Net shares

+0.00

Net value

-$3.73M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	6/2/2026	M · Option Exercise	+9.50K	$146.03	$1.39M	23.4%	40.51K	50.01K
Common Stock Direct	6/2/2026	S · Sale	−1.16K	$535.69	$621.40K	2.3%	50.01K	48.85K
Common Stock Direct	6/2/2026	S · Sale	−2.06K	$536.62	$1.10M	4.2%	48.85K	46.80K
Common Stock Direct	6/2/2026	S · Sale	−1.46K	$537.62	$787.08K	3.1%	46.80K	45.33K
Common Stock Direct	6/2/2026	S · Sale	−1.15K	$538.81	$619.09K	2.5%	45.33K	44.18K
Common Stock Direct	6/2/2026	S · Sale	−2.31K	$539.83	$1.25M	5.2%	44.18K	41.87K
Common Stock Direct	6/2/2026	S · Sale	−641.00	$540.48	$346.45K	1.5%	41.87K	41.23K
Common Stock Direct	6/2/2026	S · Sale	−440.00	$541.68	$238.34K	1.1%	41.23K	40.79K
Common Stock Direct	6/2/2026	S · Sale	−280.00	$543.26	$152.11K	0.7%	40.79K	40.51K
Total			+0.00		-$3.73M

Derivative Transactions1

Stock Option

Direct

M · Option Exercise

Converts to

Common Stock

9.50K shares

−9.50K

Strike price

146.03

Held after

116.91K

Exercisable

—

6/2/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock Option Direct	Common Stock9.50K shares	6/2/2026	M · Option Exercise	−9.50K	146.03	—	116.91K

Non-Derivative Holdings (Post-Transaction)5

Common Stock

Indirect

Shares owned249.11K

Common Stock

Indirect

Shares owned324.44K

Common Stock

Indirect

Shares owned8.90K

Common Stock

Indirect

Shares owned166.00

Common Stock

Indirect

Shares owned45.60K

Total

628.22K indirect628.22K

Security Title	Shares Owned	Ownership Type
Common Stock	249.11K	Indirect
Common Stock	324.44K	Indirect
Common Stock	8.90K	Indirect
Common Stock	166.00	Indirect
Common Stock	45.60K	Indirect
Total	628.22K	628.22K indirect

Derivative Holdings (Post-Transaction)0

No derivative holdings reported